Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00467051
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:10.549648+00:00
Published At
2015-03-20T00:00:00+00:00
Record Updated At
2018-08-29
Results Posted At
2015-03-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Childhood Extracranial Germ Cell Tumor", "Childhood Extragonadal Malignant Germ Cell Tumor", "Childhood Malignant Ovarian Germ Cell Tumor", "Childhood Malignant Testicular Germ Cell Tumor", "Ovarian Choriocarcinoma", "Ovarian Embryonal Carcinoma", "Ovarian Yolk Sac Tumor", "Recurrent Childhood Malignant Germ Cell Tumor", "Recurrent Malignant Testicular Germ Cell Tumor", "Recurrent Ovarian Germ Cell Tumor", "Testicular Choriocarcinoma", "Testicular Embryonal Carcinoma", "Testicular Mixed Choriocarcinoma and Embryonal Carcinoma", "Testicular Mixed Choriocarcinoma and Yolk Sac Tumor", "Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor", "Testicular Yolk Sac Tumor"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-08-29"
protocolSection.identificationModule.nctId
"NCT00467051"
protocolSection.identificationModule.officialTitle
"Treatment of Recurrent or Resistant Pediatric Malignant Germ Cell Tumors With Paclitaxel, Ifosfamide and Carboplatin"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2015-03-20"

Study condition terms

  • Childhood Extracranial Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Extragonadal Malignant Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Malignant Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Childhood Malignant Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Ovarian Choriocarcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Embryonal Carcinoma (protocolSection.conditionsModule.conditions)
  • Ovarian Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Childhood Malignant Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Malignant Testicular Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Recurrent Ovarian Germ Cell Tumor (protocolSection.conditionsModule.conditions)
  • Testicular Choriocarcinoma (protocolSection.conditionsModule.conditions)
  • Testicular Embryonal Carcinoma (protocolSection.conditionsModule.conditions)
  • Testicular Mixed Choriocarcinoma and Embryonal Carcinoma (protocolSection.conditionsModule.conditions)
  • Testicular Mixed Choriocarcinoma and Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor (protocolSection.conditionsModule.conditions)
  • Testicular Yolk Sac Tumor (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.